In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.

New guidelines from the European Society of Urogenital Radiology (ESUR) offer pertinent principles and recommendations for MRI use in considering fertility-sparing treatments for women with ovarian, endometrial, or cervical cancer.

Whether it is reimbursement cuts or continued attempts to push non-radiologist image interpretation, where do we draw the line between inspired protest and misspent energy criticizing things that are doomed to fail or things we have no control over?

Catch up on the top radiology content of the past week.

Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.

For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.

The CleaRecon DL software reportedly removes streak artifacts that can occur with the use of cone-beam computed tomography (CBCT) during interventional radiology procedures.

In a recent interview, C. Alberto Morales, M.D., discussed the impact of advances with CTA imaging and AI, and a shifting emphasis in cardiac risk stratification from stenosis to plaque burden.

In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.

The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.

Emerging research suggests that radiomic breast texture features extracted from full-field digital mammography may bolster prognostic assessments of invasive breast cancer risk beyond traditional risk factors.

The only ultrasound enhancing agent that does not contain polyethylene glycol, Optison may now be utilized to enhance echocardiogram assessment of ventricular function in pediatric patients.

Employing intelligent robotics and enhanced low-dose image quality, the uAngio AVIVA X-ray system also offers hands-free image review and movement.

The use of AI software for digital breast tomosynthesis (DBT) facilitated a higher cancer detection rate and over double the PPV for exams with abnormal interpretation, according to a newly published study.

The combination of high-performance gradient technology and AI tools with the Signa Sprint MRI reportedly facilitate enhanced MRI workflow efficiencies in cardiac and oncology imaging.

Is there an achievable balance between leisurely relaxation and cramming must-do sightseeing into a short amount of time?

Catch up on the top radiology content of the past week.

New research findings suggest that image quality and lesion conspicuity are significantly lower with ultrafast breast MRI in comparison to standard dynamic contrast-enhanced breast MRI.

While AI-enabled hippocampal segmentation on MRI offered a 95 percent AUC for differentiating between Alzheimer’s disease and normal controls in a 27-study meta-analysis, it offered significantly lower sensitivity and specificity in differentiating mild cognitive impairment.

For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.